*By Jacqueline Corba*
Freshman Congressman Matt Gaetz (R-FL) is on a mission to pass a bill that would allow for expanded medical marijuana research.
"Research can demystify who is right and who is wrong," Gaetz told Cheddar's CannaBiz Tuesday. "It's kind of nice to let the science guide our policy making."
Last week, the [Medical Marijuana Act](https://gaetz.house.gov/media/press-releases/congressman-matt-gaetz-applauds-passage-medical-cannabis-bill-through-house) sponsored by Gaetz passed the U.S. House Judicial Committee with bipartisan support.
It's a "landmark moment" Gaetz said; it's the first time Republicans in control of Congress have passed a medical marijuana bill through committee. Next it will head to the House floor for a vote.
"I'm super excited about what potential cannabis has in healthcare, and I think we'll learn a lot more if we're not so stupid as a government to make the research illegal," Gaetz said.
The act would give research institutions "safe harbor" to study the potential uses, benefits, and risks of the drug, which remains a Schedule I classification under the federal law alongside heroin and LSD.
"I think that marijuana policy has in many ways been victimized by the overall chilled relationship between the White House and the Department of Justice," Gaetz said.
"I think it is really Jeff Sessions who opposes medical marijuana, and I'm not entirely sure he and President Trump will be on one another's Christmas lists going forward."
For Gaetz, Washington is obstructing its own view.
"Washington just needs to get out of the way so that we can really see the potential."
For full interview [click here](https://cheddar.com/videos/medical-cannabis-research-act-passes-first-hurdle-in-congress).
Attorney General William Barr, one of President Donald Trump’s staunchest allies, is resigning amid lingering tension with the president over the president’s baseless claims of election fraud and the investigation into President-elect Joe Biden’s son.
Presidential electors have given Joe Biden a majority of their votes, formalizing his victory in last month’s election. California’s 55 votes put Biden over the top Monday.
A bipartisan group of lawmakers is unveiling a proposal for COVID-19 relief as Congress searches for a final agreement.
Federal Reserve policymakers face an unusual conundrum as they meet this week: A short-term economic outlook that is worsening while the longer-term picture is brightening thanks to the emergence of coronavirus vaccines.
Rep. Barbara Lee (D-Calif. 13th District) talked to Cheddar about her hopes that the American people will join in the push toward an equitable cannabis industry.
As members of the Electoral College meet to cast their votes for the 2020 presidential election, Cheddar explores how the body works and whether it's the best option.
The Supreme Court on Friday rejected a lawsuit backed by President Donald Trump to overturn Joe Biden’s election victory, ending a desperate attempt to get legal issues rejected by state and federal judges before the nation’s highest court and subvert the will of voters.
Sen. Tina Smith (D-Minn.) joined Cheddar to discuss the need for the federal government to provide more help to states in order to effectively distribute the COVID vaccines.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Sen. Mike Lee of Utah objected to the creation of the two proposed Smithsonian museums.
